Sign in

CIK 0000012239 · Non-accelerated filer<br>Smaller reporting company

Dominari Holdings Inc.

Sign in to watch
Ticker
DOMH
Exchange
Nasdaq
Industry
Security Brokers, Dealers & Flotation Companies
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520849320
Phone
(212) 393-4540
Business address
725 FIFTH AVENUE, 22ND FLOOR, NEW YORK, NY, 10022
Former names
Aikido Pharma Inc., AIkido Pharma Inc., SPHERIX INC, BIOSPHERICS INC
  1. 4 Open-market buy COO bought 1,500 shares at $2.94 ($4,412)
  2. 4 Grant or award Director acquired 529,715 shares (grant or award)
  3. 4 Open-market buy CEO bought 1,319 shares at $2.87 ($3,792)
  4. 4 Open-market buy CEO bought 506 shares at $2.89 ($1,460)
  5. 4 Open-market buy Director bought 1,500 shares at $2.76 ($4,146)
  6. 4 Open-market buy Director bought 424 shares at $2.59 ($1,097)
  7. 4 Open-market buy Director bought 2,000 shares at $2.59 ($5,180)
  8. 4 Open-market buy Director bought 58 shares at $2.54 ($148)
  9. 4 Open-market buy CEO bought 2,000 shares at $2.75 ($5,500)
  10. 4 Open-market buy Director bought 2,000 shares at $2.94 ($5,877)
  11. 4 Open-market buy CEO bought 2,000 shares at $2.77 ($5,538)
  12. 4 Open-market buy Director bought 2,000 shares at $2.77 ($5,539)
  13. 4 Open-market buy Director bought 2,000 shares at $2.71 ($5,423)
  14. 4 Open-market buy CEO bought 2,000 shares at $2.77 ($5,535)
  15. 4 Open-market buy COO bought 5,698 shares at $3.51 ($19,999)
  16. 4 Open-market buy CEO bought 30,000 shares at $3.44 ($103,143)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Director bought 6,000 shares at $3.59 ($21,528)
  19. 4 Open-market buy Director bought 5,000 shares at $3.59 ($17,965)
  20. 4 Open-market buy Director bought 5,000 shares at $3.71 ($18,525)

Page 5 of 17 · 335 filings